z-logo
open-access-imgOpen Access
<p>MicroRNA-155-3p promotes breast cancer progression through down-regulating CADM1</p>
Author(s) -
Guochao Zhang,
Lele Zhong,
Hao Luo,
Shibing Wang
Publication year - 2019
Publication title -
oncotargets and therapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s206180
Subject(s) - carcinogenesis , breast cancer , cancer research , microrna , mir 155 , cancer , cell growth , biology , transfection , apoptosis , flow cytometry , medicine , cell culture , microbiology and biotechnology , gene , biochemistry , genetics
Cell adhesion molecule 1 (CADM1) functions as a tumor suppressor and has been identified to be frequently inactivated in breast cancer, and closely associated with patients' poor prognosis and advanced TNM stage. However, the mechanisms underlying CADM1 in breast cancer progression remains incompletely clear. miR-155, a predicted modulator of CADM1 was reported to be overexpressed in breast cancer, and its high expression level was closely related to the malignant progression of breast cancer. The present study aimed to explore whether miR-155-3p could modulate CADM1 expression and then involved in the progression of breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom